PGY2 Oncology
JOIN US FOR ONE OF OUR UPCOMING VIRTUAL INFORMATION SESSIONS! DATES/TIMES/LINKS ARE LOCATED ON THE MAIN UNC MEDICAL CENTER RESIDENCY PROGRAM HOMEPAGE
*RPD Office Hours on 12/2/2025 & 12/17/2025*
Thank you for your interest in our program! We look forward to connecting with you and discussing our program in more detail! Jessica Auten, PGY2 Oncology RPD, will meet with interested candidates during scheduled 15-minute sessions on 12/2/2025 and 12/17/2025. Please review the available time slots and sign up at this link.
Interviews for the PGY2 Oncology program will be conducted fully virtually.
Overview
The UNC Hospitals PGY2 Oncology Pharmacy Residency Program is an ASHP-accredited postgraduate training experience dedicated to developing advanced practitioners in oncology pharmacy. The program emphasizes clinical excellence, leadership, and scholarly engagement, preparing pharmacists to deliver compassionate, evidence-based care across a variety of oncology practice settings.
Residents benefit from a comprehensive curriculum supported by innovative practice models and a culture that fosters professional growth. The program promotes leadership development and encourages scholarly activity. A collegial and collaborative environment ensures that residents are well-supported as they advance their clinical and academic competencies.
Program Purpose
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Collaboration with the North Carolina Basnight Cancer Hospital
The UNC Hospitals PGY2 Oncology Pharmacy Residency is closely aligned with the North Carolina Basnight Cancer Hospital, the clinical home of the UNC Lineberger Comprehensive Cancer Center. This 315,000-square-foot facility, dedicated in 2009, supports a comprehensive, interdisciplinary cancer care program that serves patients from all 100 counties in North Carolina, with over 270,000 patient visits annually.
Within this high-volume and diverse oncology service line, the Department of Pharmacy plays an integral role in delivering high-quality care across both acute and ambulatory settings. Oncology pharmacists at UNC are recognized for their clinical expertise and collaborative contributions, having received five ASHP Best Practice Awards. The institution fosters a progressive practice model that emphasizes innovation, supported by external funding and a commitment to continuous improvement.
Residents are exposed to a wide range of clinical experiences and practice environments, enabling them to develop the confidence, knowledge, and skills necessary for success in advanced oncology pharmacy roles. The program’s strong emphasis on excellence, innovation, and collaboration ensures that graduates are well-prepared to meet the evolving demands of oncology care and contribute as leaders in the profession.
About the Residency Program Director
Dr. Auten is an acute care malignant hematology specialist at UNC Hospitals and an Assistant Professor of Clinical Education at the UNC Eshelman School of Pharmacy (ESOP). She completed her undergraduate training at the University of North Carolina in Chapel Hill, NC and her Doctor of Pharmacy from UNC ESOP. She completed a PGY1 pharmacy practice and PGY2 oncology pharmacy residency at Virginia Commonwealth University Health System in Richmond, VA. Dr. Auten’s practice and research interests focus on acute leukemia, supportive care, and patient education.
